Close

Interpace Diagnostics' (IDXG) Says Horizon Blue Cross Blue Shield of New Jersey to Cover its Molecular Thyroid Tests

February 26, 2018 8:34 AM EST Send to a Friend
Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login